News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,377 Results
Type
Article (42144)
Company Profile (267)
Press Release (688950)
Multimedia
Podcasts (95)
Webinars (20)
Section
Business (205243)
Career Advice (2054)
Deals (35667)
Drug Delivery (128)
Drug Development (81692)
Employer Resources (173)
FDA (16543)
Job Trends (15016)
News (347621)
Policy (32907)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2602)
Accelerated approval (45)
Adcomms (26)
Allergies (169)
Alliances (49699)
ALS (203)
Alzheimer's disease (1774)
Antibody-drug conjugate (ADC) (431)
Approvals (16902)
Artificial intelligence (637)
Autoimmune disease (256)
Automation (52)
Bankruptcy (362)
Best Places to Work (11655)
BIOSECURE Act (20)
Biosimilars (217)
Biotechnology (176)
Bladder cancer (185)
Brain cancer (71)
Breast cancer (724)
Cancer (5683)
Cardiovascular disease (458)
Career advice (1744)
Career pathing (41)
CAR-T (320)
CDC (56)
Celiac Disease (3)
Cell therapy (853)
Cervical cancer (46)
Clinical research (70724)
Collaboration (2012)
Company closure (5)
Compensation (1332)
Complete response letters (77)
COVID-19 (2743)
CRISPR (104)
C-suite (1070)
Cystic fibrosis (150)
Data (7554)
Decentralized trials (3)
Denatured (30)
Depression (158)
Dermatology (76)
Diabetes (577)
Diagnostics (6912)
Digital health (53)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (311)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (274)
Earnings (91551)
Editorial (64)
Employer branding (21)
Employer resources (152)
Events (119489)
Executive appointments (1063)
FDA (20165)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1680)
Gene editing (226)
Generative AI (55)
Gene therapy (691)
GLP-1 (1050)
Government (4748)
Grass and pollen (6)
Guidances (403)
Healthcare (19026)
HIV (80)
Huntington's disease (55)
IgA nephropathy (93)
Immunology and inflammation (285)
Immuno-oncology (86)
Indications (176)
Infectious disease (3079)
Inflammatory bowel disease (206)
Inflation Reduction Act (14)
Influenza (135)
Intellectual property (284)
Interviews (328)
IPO (16672)
IRA (50)
Job creations (3669)
Job search strategy (1444)
JPM (60)
Kidney cancer (18)
Labor market (96)
Layoffs (561)
Leadership (38)
Legal (7994)
Liver cancer (100)
Longevity (32)
Lung cancer (757)
Lymphoma (421)
Machine learning (58)
Management (59)
Manufacturing (997)
MASH (179)
Medical device (13914)
Medtech (14012)
Mergers & acquisitions (20217)
Metabolic disorders (1469)
mRNA (197)
Multiple sclerosis (183)
NASH (18)
Neurodegenerative disease (400)
Neuropsychiatric disorders (103)
Neuroscience (3246)
Neurotech (1)
NextGen: Class of 2026 (6556)
Non-profit (4546)
Now hiring (76)
Obesity (690)
Opinion (285)
Ovarian cancer (208)
Pain (246)
Pancreatic cancer (288)
Parkinson's disease (352)
Partnered (33)
Patents (583)
Patient recruitment (643)
Peanut (61)
People (59583)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22041)
Phase 2 (31137)
Phase 3 (23193)
Pipeline (7928)
Policy (311)
Postmarket research (2587)
Preclinical (9395)
Press Release (64)
Prostate cancer (291)
Psychedelics (52)
Radiopharmaceuticals (320)
Rare diseases (1035)
Real estate (6001)
Recruiting (70)
Regulatory (25359)
Reports (55)
Research institute (2421)
Resumes & cover letters (355)
Rett syndrome (36)
RNA editing (21)
RSV (88)
Schizophrenia (176)
Series A (280)
Series B (207)
Service/supplier (11)
Sickle cell disease (110)
Special edition (23)
Spinal muscular atrophy (165)
Sponsored (47)
Startups (3648)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (63)
Vaccines (1082)
Venture capital (105)
Weight loss (445)
Women's health (123)
Worklife (20)
Date
Today (39)
Last 7 days (760)
Last 30 days (2763)
Last 365 days (30152)
2026 (10625)
2025 (30233)
2024 (35273)
2023 (40135)
2022 (51240)
2021 (55760)
2020 (54158)
2019 (46689)
2018 (35146)
2017 (32192)
2016 (31609)
2015 (37676)
2014 (31453)
2013 (26474)
2012 (28697)
2011 (29407)
2010 (27480)
Location
Africa (746)
Alabama (91)
Alaska (7)
Arizona (342)
Arkansas (14)
Asia (39915)
Australia (6532)
California (12819)
Canada (3670)
China (1301)
Colorado (547)
Connecticut (554)
Delaware (390)
Europe (86079)
Florida (1925)
Georgia (411)
Hawaii (3)
Idaho (63)
Illinois (1026)
India (88)
Indiana (585)
Iowa (23)
Japan (514)
Kansas (129)
Kentucky (50)
Louisiana (40)
Maine (75)
Maryland (1544)
Massachusetts (9134)
Michigan (355)
Minnesota (697)
Mississippi (6)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (138)
New Hampshire (84)
New Jersey (3394)
New Mexico (28)
New York (3367)
North Carolina (1630)
North Dakota (8)
Northern California (6393)
Ohio (380)
Oklahoma (23)
Oregon (42)
Pennsylvania (2582)
Puerto Rico (28)
Rhode Island (50)
South America (1123)
South Carolina (85)
South Dakota (2)
Southern California (5046)
Tennessee (206)
Texas (2027)
United States (45315)
Utah (382)
Vermont (1)
Virginia (307)
Washington D.C. (80)
Washington State (1028)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
731,377 Results for "sun microsystems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Sun Pharma beams up Organon in $11.75B acquisition
Sun Pharmaceutical is bringing Merck spinoff Organon into the fold, paying $11.75 billion in hopes of becoming a top global biosimilar player.
April 27, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Sun Pharma signs Definitive Agreement to Acquire Organon
April 26, 2026
·
11 min read
Venture capital
Biotech has become a good news story. Let the sun shine
Doubling survival in pancreatic cancer, a long-fought rare disease approval, a massive IPO and ambitious biotech entrepreneurs have
BioSpace
Senior Editor Annalee Armstrong feeling upbeat about the biotech scene.
April 20, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®
November 13, 2025
·
4 min read
Press Releases
Sun Pharma Highlights Advances in Alopecia Areata, Psoriasis, and Acne Research at 2026 AAD Annual Meeting
March 30, 2026
·
14 min read
Press Releases
Sun Pharma Showcases Data Across its Dermatology & Immunology Portfolio at 2026 Winter Clinical Miami
March 1, 2026
·
14 min read
Press Releases
U.S. Patent Office Issues Final Written Decision Finding All Challenged Claims of Sun Pharma’s Patent 11,697,028 To Be Unpatentable
February 26, 2026
·
3 min read
Press Releases
Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
January 16, 2026
·
8 min read
Mergers & acquisitions
At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun
Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a break after a few tough years.
January 9, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Sun Pharma Announces Jeremy Allen as Vice President, Corporate Affairs for North America
October 23, 2025
·
3 min read
1 of 73,138
Next
